Activation of OX40, a co-stimulatory molecule belonging to the TNF receptor superfamily, leads to expansion of CD4+ and CD8+ T cells resulting in tumour rejection in murine models (Weinberg et al, 2000). The gene discussed is CD4; the disease is neoplasm.